Cytokinetics launches ASPEN-HCM real-world study of MYQORZO (aficamten)

Cytokinetics launched the ASPEN-HCM real-world study evaluating MYQORZO (aficamten) in symptomatic obstructive hypertrophic cardiomyopathy.